TY  - GEN
AU  - Gane,Edward J
AU  - Kowdley,Kris V
AU  - Pound,David
AU  - Stedman,Catherine A M
AU  - Davis,Mitchell
AU  - Etzkorn,Kyle
AU  - Gordon,Stuart C
AU  - Bernstein,David
AU  - Everson,Gregory
AU  - Rodriguez-Torres,Maribel
AU  - Tsai,Naoky
AU  - Khalid,Omer
AU  - Yang,Jenny C
AU  - Lu,Sophia
AU  - Dvory-Sobol,Hadas
AU  - Stamm,Luisa M
AU  - Brainard,Diana M
AU  - McHutchison,John G
AU  - Tong,Myron
AU  - Chung,Raymond T
AU  - Beavers,Kimberly
AU  - Poulos,John E
AU  - Kwo,Paul Y
AU  - Nguyen,Mindie H
TI  - Efficacy of Sofosbuvir, Velpatasvir, and GS-9857 in Patients With Hepatitis C Virus Genotype 2, 3, 4, or 6 Infections in an Open-Label, Phase 2 Trial
SN  - 1528-0012
PY  - 2017///0531
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Aminoisobutyric Acids
KW  - Antiviral Agents
KW  - therapeutic use
KW  - Carbamates
KW  - Cyclopropanes
KW  - Drug Administration Schedule
KW  - Drug Combinations
KW  - Drug Therapy, Combination
KW  - Female
KW  - Follow-Up Studies
KW  - Genotype
KW  - Hepacivirus
KW  - genetics
KW  - Hepatitis C, Chronic
KW  - drug therapy
KW  - Heterocyclic Compounds, 4 or More Rings
KW  - Humans
KW  - Lactams, Macrocyclic
KW  - Leucine
KW  - analogs & derivatives
KW  - Macrocyclic Compounds
KW  - Male
KW  - Middle Aged
KW  - Proline
KW  - Quinoxalines
KW  - Serine Proteases
KW  - Sofosbuvir
KW  - Sulfonamides
KW  - Treatment Outcome
KW  - Viral Nonstructural Proteins
KW  - Young Adult
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study
UR  - https://doi.org/10.1053/j.gastro.2016.07.038
ER  -